We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

EU Approves Novartis's laBCC Therapy

News   Aug 24, 2015

 
EU Approves Novartis's laBCC Therapy
 
 
 

RELATED ARTICLES

Gene Therapy Restores Immunity in Infants With Rare Immunodeficiency Disease

News

A small clinical trial has shown that gene therapy can safely correct the immune systems of infants newly diagnosed with a rare, life-threatening inherited disorder in which infection-fighting immune cells do not develop or function normally.

READ MORE

Technology Senses How Parkinson's Patients Respond to Medication

News

Researchers have developed an innovative way to automatically and reliably detect and monitor medication "on" and "off" states in Parkinson's disease patients.

READ MORE

Combining CRISPR With Drug Discovery to Understand Treatment Efficacy

News

Researchers combine CRISPR gene-editing technology with drug discovery to understand why treatment works (or doesn’t).

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE